Literature DB >> 23838030

Classification and natural history of the neuronal ceroid lipofuscinoses.

Jonathan W Mink1, Erika F Augustine, Heather R Adams, Frederick J Marshall, Jennifer M Kwon.   

Abstract

The neuronal ceroid lipofuscinoses represent a group of disorders characterized by neurodegeneration and intracellular accumulation of an auto-fluorescent lipopigment (ceroid lipofuscin). Together, they represent the most prevalent class of childhood neurodegenerative disease. The neuronal ceroid lipofuscinoses encompass several distinct biological entities that vary in age of onset, specific neurologic phenotype, and rate of progression. In this review, we describe 9 major forms and present a classification scheme. Understanding the age of onset, clinical features, and natural history can inform rational diagnostics. Better knowledge of the natural histories of these disorders is necessary to shed light on the underlying pathobiology and to develop new therapeutics.

Entities:  

Keywords:  Batten disease; blindness; dementia; epilepsy; movement disorders; neurodegeneration

Mesh:

Year:  2013        PMID: 23838030      PMCID: PMC3979348          DOI: 10.1177/0883073813494268

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  35 in total

Review 1.  The neuronal ceroid-lipofuscinoses.

Authors:  Matti Haltia
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

2.  Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

Authors:  Elisabeth A de Blieck; Erika F Augustine; Frederick J Marshall; Heather Adams; Jennifer Cialone; Leon Dure; Jennifer M Kwon; Nicole Newhouse; Katherine Rose; Paul G Rothberg; Amy Vierhile; Jonathan W Mink
Journal:  Contemp Clin Trials       Date:  2013-04-26       Impact factor: 2.226

3.  Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients.

Authors:  P Santavuori; M Haltia; J Rapola; C Raitta
Journal:  J Neurol Sci       Date:  1973-03       Impact factor: 3.181

4.  A dominant form of neuronal ceroid-lipofuscinosis.

Authors:  D H Boehme; J C Cottrell; S C Leonberg; W Zeman
Journal:  Brain       Date:  1971       Impact factor: 13.501

5.  Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse.

Authors:  Hanlin Gao; Rose-Mary N Boustany; Janice A Espinola; Susan L Cotman; Lakshmi Srinidhi; Kristen Auger Antonellis; Tammy Gillis; Xuebin Qin; Shumei Liu; Leah R Donahue; Roderick T Bronson; Jerry R Faust; Derek Stout; Jonathan L Haines; Terry J Lerner; Marcy E MacDonald
Journal:  Am J Hum Genet       Date:  2001-12-21       Impact factor: 11.025

6.  Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.

Authors:  Robert Steinfeld; Peter Heim; Henning von Gregory; Kerstin Meyer; Kurt Ullrich; Hans H Goebel; Alfried Kohlschütter
Journal:  Am J Med Genet       Date:  2002-11-01

Review 7.  Northern epilepsy, a new member of the NCL family.

Authors:  S Ranta; A E Lehesjoki
Journal:  Neurol Sci       Date:  2000       Impact factor: 3.307

8.  Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.

Authors:  W A Mitchell; R B Wheeler; J D Sharp; S L Bate; R M Gardiner; U S Ranta; L Lonka; R E Williams; A E Lehesjoki; S E Mole
Journal:  Eur J Paediatr Neurol       Date:  2001       Impact factor: 3.140

9.  Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.

Authors:  Meral Topçu; Hüseyin Tan; Dilek Yalnizoğlu; Alp Usubütün; Işil Saatçi; Müjgan Aynaci; Banu Anlar; Haluk Topaloğlu; Güzide Turanli; Gülşen Köse; Sabiha Aysun
Journal:  Turk J Pediatr       Date:  2004 Jan-Mar       Impact factor: 0.552

10.  Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease.

Authors:  S-L Vanhanen; J Puranen; T Autti; R Raininko; K Liewendahl; P Nikkinen; P Santavuori; P Suominen; K Vuori; A-M Häkkinen
Journal:  Neuropediatrics       Date:  2004-02       Impact factor: 1.947

View more
  38 in total

Review 1.  New zebrafish models of neurodegeneration.

Authors:  Rebeca Martín-Jiménez; Michelangelo Campanella; Claire Russell
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 2.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

3.  Progressive retinal degeneration and accumulation of autofluorescent lipopigments in Progranulin deficient mice.

Authors:  Brian P Hafler; Zoe A Klein; Z Jimmy Zhou; Stephen M Strittmatter
Journal:  Brain Res       Date:  2014-09-16       Impact factor: 3.252

4.  Intermittent Short Sleep Results in Lasting Sleep Wake Disturbances and Degeneration of Locus Coeruleus and Orexinergic Neurons.

Authors:  Yan Zhu; Polina Fenik; Guanxia Zhan; Rebecca Somach; Ryan Xin; Sigrid Veasey
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

5.  Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis.

Authors:  Erika F Augustine; Heather R Adams; Christopher A Beck; Amy Vierhile; Jennifer Kwon; Paul G Rothberg; Frederick Marshall; Robert Block; James Dolan; Jonathan W Mink
Journal:  Dev Med Child Neurol       Date:  2014-11-11       Impact factor: 5.449

6.  Congenital CLN disease in two siblings.

Authors:  Sascha Meyer; Umut Yilmaz; Yoo-Jin Kim; Robert Steinfeld; Gabriele Meyberg-Solomayer; Barbara Oehl-Jaschkowitz; Andreas Tzschach; Ludwig Gortner; Julia Igel; Otto Schofer
Journal:  Wien Med Wochenschr       Date:  2015-06-10

Review 7.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 8.  Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).

Authors:  Nihar Kinarivala; Paul C Trippier
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446

9.  BATTEN DISEASE CAUSED BY A NOVEL MUTATION IN THE PPT1 GENE.

Authors:  Tatyana I Metelitsina; Darrel J Waggoner; Michael A Grassi
Journal:  Retin Cases Brief Rep       Date:  2016

Review 10.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.